Sign in
Download Opera News App

DISEASE PREVENTION AND TREATMENT

ZyVersa Therapeutics and University of Miami Awarded a Grant from The Michael J. Fox Foundation to Determine if Inhibition of Microglial Inflammasome Activation with IC 100 Blocks Neuroinflammation Dr

ZyVersa Therapeutics and University of Miami Awarded a Grant from The Michael J. Fox Foundation to Determine if Inhibition of Microglial Inflammasome Activation with IC 100 Blocks Neuroinflammation Dr

Compelling evidence that chronic neuroinflammation induces neurodegeneration in Parkinson's disease (PD) Hypothesized that microglial inflammasome activation propagates chronic neuroinflammation in PD IC 100, a CNS-penetrating monoclonal ASC Inhibitor, targets multiple types of inflammasomes to block initiation and perpetuation of damaging chronic inflammation WESTON, Fla., July 27, 2022 /PRNewswire/ -- ZyVersa Therapeutics, Inc. (ZyVersa),...

Read Full Story
ASC Michael J. Fox Foundation The ZyVersa ZyVersa Therapeutics

Top News

US POLITICS

Voters decide primary elections in Wyoming and Alaska: LIVE UPDATES

foxnews.com
Voters decide primary elections in Wyoming and Alaska: LIVE UPDATES

US POLITICS

Voters decide primary elections in Wyoming and Alaska: LIVE UPDATES

foxnews.com

FRAUD

Former Democratic California congressman TJ Cox indicted for money laundering and fraud

foxnews.com
Former Democratic California congressman TJ Cox indicted for money laundering and fraud

FRAUD

Former Democratic California congressman TJ Cox indicted for money laundering and fraud

foxnews.com

comments

Load app to read more comments